{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:00Z","timestamp":1793332320464,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.2174\/138945008783431781","type":"journal-article","created":{"date-parts":[[2008,1,19]],"date-time":"2008-01-19T15:24:41Z","timestamp":1200756281000},"page":"14-36","source":"Crossref","is-referenced-by-count":208,"title":["Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy"],"prefix":"10.2174","volume":"9","author":[{"given":"Peter","family":"Oates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/66265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T04:15:21Z","timestamp":1448252121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-4501&volume=9&issue=1&spage=14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138945008783431781","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}